Roche Sees Glass Half Full After Ipatasertib Data

Hit One Co-Primary Endpoint, Missed The Other

 
• By Kevin Grogan
  
Glass_Of_Water
Roche accentuates the positive in ipatasertib study • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Anticancer

More from Therapeutic Category